Search - tctmd.com

Displaying 81 - 100 of 126

Sort: Relevancy | Date

Presentation THT 2022

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Physiological Rationale and Devices for Interatrial Shunts

Presenter: JoAnn Lindenfeld

February 01, 2022

Presentation THT 2022

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Liviu Klein

February 01, 2022

Presentation THT 2022

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Roham Zamanian

February 01, 2022

Presentation TCT 2021

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Presenter: Daniel Burkhoff

November 06, 2021

Presentation TCT 2021

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Presenter: Harlee Sorkin

November 05, 2021

Presentation TCT 2021

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Presenter: Jacob Kriegel

November 05, 2021

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

Presentation TCT 2020

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Presenter: Daniel Burkhoff

October 17, 2020

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

Presentation TCT 2019

NoYo Interatrial Shunting

Presenter: Chaim Lotan

September 28, 2019

Presentation TCT 2019

A Novel, Stentless RF-Based Shunt Solution for Advanced Heart Failure (Noya Medical)

Presenter: Chaim Lotan

September 26, 2019

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

Presentation TCT 2018

Interatrial Shunts II: V-wave

Presenter: James E. Udelson, Clyde W. Yancy, JoAnn Lindenfeld

September 22, 2018

Presentation TCT 2018

Interatrial Shunts I: Corvia

Presenter: James E. Udelson, Clyde W. Yancy, Ted Feldman

September 22, 2018

News Industry News

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

August 27, 2018

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Industry News

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

November 14, 2017

Presentation TCT 2017

Inter-atrial Shunts II: Corvia

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Ted Feldman

October 31, 2017

Advertisement

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Physiological Rationale and Devices for Interatrial Shunts

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

NoYo Interatrial Shunting

A Novel, Stentless RF-Based Shunt Solution for Advanced Heart Failure (Noya Medical)

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Interatrial Shunts II: V-wave

Interatrial Shunts I: Corvia

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

Inter-atrial Shunts II: Corvia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content